Takeda Pharmaceutical Company Takeda Pharmaceutical Company Limited Public (TYO: 4502)Founded1781HeadquartersOsaka, JapanKey peopleKunio Takeda,
Revenue more than $14B (SGD) Industry Pharmaceutical & Biotechnology Headquarters1-1, Nihonbashi-Honcho 2-...Show more Link Takeda Pharmaceuticals website Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to...
Revenue (2023)$29.5B5.9%(2023 vs 2022) EPSXYZ Net Income (2023)XYZ-54.6%(2023 vs 2022) Market Cap*$47.7B Net Profit Margin (2023)XYZ-57.1%(2023 vs 2022) * As ofand is in US$ View Takeda Pharmaceutical Co Ltd financials Takeda Pharmaceutical Co Ltd premium industry data and analytics...
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) (“ARIAD”) for $24.00 per share in cash. “We are very pleased to have completed the acquisition of ARIAD Pharmaceuticals. The additio...
Takeda Pharmaceutical Company Limited price and volume Combination chart with 2 data series. Chart represents Takeda Pharmaceutical Company Limited price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has 2 Y axes displaying symbol price, and sy...
Company Fundamentals Debt-to-equity ratio (most recent) Below Average 63.42 Operating Margins (TTM) Average 13.48% Revenue (TTM) Above Average $30218.46 million Year-Over-Year Fundamentals See More Takeda Pharmaceutical Co - ADR Vitals Updated 05/05/2025 Quotes delayed at least 15 minutes. Market...
A business analysis of Takeda Pharmaceutical Co. Ltd., a pharmaceuticals company located in Osaka, Japan is presented, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. The increasing market share of the internally-developed drugs has driven the revenue...
For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any ora...
Takeda Pharmaceutical Company Limited SWOT Analysis.The article presents information on Osaka, Japan-based Takeda Pharmaceutical Co. Ltd., a research-based global company which focuses on pharmaceuticals and offers products in about 100 countries. The company's strengths and weaknesses, its revenue and...
Discovery Company profile page for Takeda Pharmaceutical Co., Ltd. including technical research,competitor monitor,market trends,company profile& stock symbol